Search

GSK CEO Andrew Witty dedicates albendazole facility in Nashik to WHO’s Global Programme to Eliminate LF

(GSK) CEO Andrew Witty today dedicated a new production facility at its Nashik site in India to the manufacture of albendazole.

First published: 07 March 2010

GSK increases support for WHO strategy to improve children’s health with new 5-year commitment to expand donations of albendazole medicine

At the launch of the World Health Organizations (WHO) first report on Neglected Tropical Diseases today.

First published: 13 October 2010

GSK gives update on agreement with World Health Organization to support de-worming of school age children in endemic countries

First African countries, Togo and Rwanda, receive albendazole donations to scale-up school based de-worming programmes for children at risk.

First published: 12 September 2011

Basis of reporting for social and governance 2025

First published: 05 March 2026

Basis Of Reporting For Social And Governance 2024

First published: 27 February 2025

Q1 2023 ESG quarterly update

First published: 26 March 2025

Our contribution to the SDGs

First published: 26 March 2025

Trust Progress Summary 2020

First published: 26 March 2025

Summary of progress on our Trust commitments in 2019

First published: 26 March 2025

2018 progress summary

First published: 26 March 2025